5 news items
Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?
HEPA
22 Apr 24
to support a registrational trial with our current cash resources, we have opted to wind down the program and assure that patients are transitioned out
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
AAOI
AGBA
AGRI
22 Apr 24
.
Assure Holdings Corp. (NASDAQ:IONM) rose 25% to $0.55 after dipping more
Hepion Pharmaceuticals Says Given The Number Of Enrolled NASH Patients To Date And The Low Probability Of Generating Relevant Efficacy Data To Support A Registrational Trial With Our Current Cash Resources, We Have Opted To Wind Down The Program And Assure That Patients Are Transitioned Out Of The Trial In A Safe And Compliant Manner"
HEPA
19 Apr 24
trial with our current cash resources, we have opted to wind down the program and assure that patients are transitioned out of the trial in a safe
Hepion Pharmaceuticals Initiates Wind-Down Activities In Phase 2b 'ASCEND-NASH' Trial
HEPA
19 Apr 24
trial with our current cash resources, we have opted to wind down the program and assure that patients are transitioned out of the trial in a safe
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b 'ASCEND-NASH' Trial
HEPA
19 Apr 24
relevant efficacy data to support a registrational trial with our current cash resources, we have opted to wind down the program and assure
- Prev
- 1
- Next